Action IPSC CENTURY THERAPEUTICS, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Century Therapeutics, Inc.

Actions

IPSC

US15673T1007

Marché Fermé - Nasdaq
Autres places de cotation
 22:00:00 24/04/2024 		Varia. 5j. Varia. 1 janv.
2,96 USD -5,43 % Graphique intraday de Century Therapeutics, Inc. +4,23 % -10,84 %
12/04 CENTURY THERAPEUTICS, INC. : Piper Sandler reste à l'achat ZM
11/04 Syncona accepte de vendre sa participation dans une entreprise pour un montant de 7,4 millions de livres sterling AN

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Century Therapeutics to Present at Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
Syncona agrees to sell stake in investee company for GBP7.4 million
Syncona to Sell Stake in Portfolio Company to Century Therapeutics
Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics
Century Therapeutics Announces Plans to Expand Clinical Development for Its Lead Program, CNTY-101
Century Therapeutics, Inc. acquired Clade Therapeutics, Inc. from Syncona Limited for $45 million..
Century Therapeutics, Inc. announced that it expects to receive $59.999982 million in funding from a group of investors
Century Therapeutics, Inc. agreed to acquire Clade Therapeutics, Inc. from Syncona Limited for $45 million.
Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research Annual Meeting
Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting
Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
Sector Update: Health Care Stocks Retreating Late Afternoon
Century Therapeutics Shares Fall After Wider Loss, Lower Revenue in 2023
Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates
Century Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Century Therapeutics : Corporate Overview March 2024
Century Therapeutics Announces Six Upcoming Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting
Century Therapeutics to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action IPSC
  4. Actualités Century Therapeutics, Inc.
  5. Autres langues